TV News LIES

Wednesday, Sep 17th

Last update03:18:35 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Philip Morris Sues Uruguay Over Graphic Cigarette Packaging

Philip Morris sues UruguayShopping for cigarettes in Uruguay isn't a pleasant experience. Photos of decaying teeth, premature babies and...

Fourth doctor dies of Ebola in Sierra Leone

Ebola crisisSierra Leone has lost a fourth doctor to Ebola after a failed effort to transfer her...

Documents reveal how poultry firms systematically feed antibiotics to flocks

antibiotic use in chickensPervasive use fuels concerns about impact on human health, emergence of resistant superbugsMajor U.S. poultry firms...

Enterovirus 68 now sickening children in Northeast

Enterovirus 68A virus hospitalizing children in the U.S. Midwest at an unprecedented rate has now made its...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!